[Controlled clinical trial of a new drug (plafibride) for the treatment of hyperlipoproteinemia type IV (author's transl)].
D000328:Adult; D000368:Aged; D002986:Clinical Trials as Topic; D002994:Clofibrate / Q000031:analogs & derivatives*; D002995:Clofibric Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D006953:Hyperlipoproteinemia Type IV / Q000097:blood / Q000188:drug therapy*; D008055:Lipids / Q000097:blood; D008297:Male; D008875:Middle Aged; D010979:Platelet Function Tests; D011897:Random Allocation
D008055:Lipids; D002995:Clofibric Acid; C016894:plafibride; D002994:Clofibrate
Estudio de la actividad del plafibride en el tratamiento de la hiperlipoproteinemia tipo IV.